ProfileGDS4718 / 1554758_a_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 25% 31% 28% 30% 28% 27% 27% 27% 32% 28% 26% 29% 30% 25% 25% 35% 26% 28% 28% 30% 33% 27% 36% 29% 26% 24% 25% 23% 34% 33% 27% 26% 30% 30% 26% 26% 29% 34% 29% 23% 34% 29% 28% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.3579325
GSM549102patient 115, normal, homogenized [OPG study]4.6189331
GSM549104patient 119, normal, homogenized [OPG study]4.4178828
GSM549108patient 138, normal, homogenized [OPG study]4.595930
GSM549119patient 077, normal, homogenized [OPG study]4.4716828
GSM549133patient 032, cancer, homogenized [OPG study]4.3452127
GSM549139patient 042, cancer, homogenized [OPG study]4.3897427
GSM549099patient 107, normal, homogenized [OPG study]4.4468927
GSM549109patient 139, normal, homogenized [OPG study]4.639232
GSM549110patient 046, normal, homogenized [OPG study]4.4746528
GSM549114patient 063, normal, homogenized [OPG study]4.3339326
GSM549122patient 082, normal, homogenized [OPG study]4.5005829
GSM549134patient 033, cancer, homogenized [OPG study]4.5217130
GSM549136patient 036, cancer, homogenized [OPG study]4.2955125
GSM549140patient 044, cancer, homogenized [OPG study]4.2972925
GSM549111patient 047, normal, homogenized [OPG study]4.7438235
GSM549113patient 057, normal, homogenized [OPG study]4.3095826
GSM549132patient 031, cancer, homogenized [OPG study]4.4235928
GSM549137patient 038, cancer, homogenized [OPG study]4.4601728
GSM549142patient 047, cancer, homogenized [OPG study]4.6359130
GSM549100patient 110, normal, homogenized [OPG study]4.6800533
GSM549107patient 135, normal, homogenized [OPG study]4.3873527
GSM549115patient 068, normal, homogenized [OPG study]4.7269936
GSM549116patient 072, normal, homogenized [OPG study]4.4660429
GSM549120patient 078, normal, homogenized [OPG study]4.3889526
GSM549131patient 030, cancer, homogenized [OPG study]4.265724
GSM549118patient 074, normal, homogenized [OPG study]4.3518125
GSM549129patient 027, cancer, homogenized [OPG study]4.2629823
GSM549123patient 088, normal, homogenized [OPG study]4.713534
GSM549124patient 006, cancer, homogenized [OPG study]4.7204533
GSM549126patient 015, cancer, homogenized [OPG study]4.4013927
GSM549128patient 025, cancer, homogenized [OPG study]4.3379826
GSM549103patient 117, normal, homogenized [OPG study]4.5759830
GSM549117patient 073, normal, homogenized [OPG study]4.5011930
GSM549138patient 041, cancer, homogenized [OPG study]4.3708226
GSM549141patient 045, cancer, homogenized [OPG study]4.3301926
GSM549130patient 028, cancer, homogenized [OPG study]4.5265329
GSM549101patient 111, normal, homogenized [OPG study]4.7343234
GSM549105patient 128, normal, homogenized [OPG study]4.5391429
GSM549106patient 134, normal, homogenized [OPG study]4.2153723
GSM549112patient 048, normal, homogenized [OPG study]4.6844734
GSM549125patient 011, cancer, homogenized [OPG study]4.5254729
GSM549127patient 024, cancer, homogenized [OPG study]4.4588128
GSM549135patient 035, cancer, homogenized [OPG study]4.2693425